Analyzing patient data to understand TMS effects on depression and anxiety
Official title: Retrospective Analyses Evaluating the Real-World Effectiveness of NeuroStar® TMS and the Factors Associated With Clinical Outcomes
Run by Neuronetics · NCT06917339 · Data updated 2026-11-12
This study looks at real patient data to see how different factors affect the success of TMS therapy for people dealing with depression and anxiety.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 5 Years to 120 Years |
| Sex | All |
| Enrollment | 156000 (estimated) |
| Sponsor | Neuronetics Academic / other |
| Locations | 1 site (Malvern, Pennsylvania) |
| Status | Recruiting |
| Started | February 25, 2025 |
| Main results expected | December 2035 |
| Study ends | December 2035 |
| Registry record updated | April 9, 2026 |
| Trial ID | NCT06917339 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who have received TMS therapy for depression or anxiety-related conditions since November 2008.
✕Probably not a fit
Patients with incomplete treatment information or those who do not meet the inclusion criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study utilizes real-world data from the TrakStar database to analyze how various patient characteristics, symptoms, and TMS protocol parameters influence clinical outcomes in patients receiving NeuroStar TMS therapy. By examining data from patients treated since November 2008, the study aims to identify patterns and correlations that could enhance treatment efficacy. The focus is on conditions such as depression, obsessive-compulsive disorder, and anxiety depression, providing insights into the effectiveness of TMS in these populations.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment strategies for patients suffering from depression and anxiety disorders.
How similar studies have gone: Other studies utilizing real-world data to analyze TMS outcomes have shown promising results, indicating that this approach is both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female reported in database and not an invalid entry * Age reported and not an invalid entry * Treatment date of November 01, 2008 or later. Exclusion Criteria: • Incomplete information on treatment parameters
Where it's running
-
Neuronetics
Malvern, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Neha Goyal
- Email: neha.goyal@neurostar.com
- Phone: 763-528-1599
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Analyzing mental health treatment data from Greenbrook
This study looks at past treatment data from Greenbrook to see how well different mental health treatments, like NeuroStar TMS and Esketamine, work for people with depression, OCD, and anxiety.
-
Evaluating outcomes in neurosurgery using standardized measures
This study is trying to see how different factors affect the results of brain surgeries by collecting information from patients before and after their operations.
-
Using RxWell to Reduce Opioid Use After Knee or Hip Surgery
This study is testing whether a digital tool called RxWell can help people with mood disorders who are having knee or hip surgery reduce their opioid use and improve their mental health after the operation.
-
Personalized emotion regulation skills training
This study is testing if teaching people personalized ways to manage their emotions can help them feel less negative every day compared to using standard methods.
-
Evaluating the impact of self-help CBT in primary care behavioral health
This study is testing if adding guided self-help therapy to regular mental health care can help patients feel better and improve their daily lives.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.